AI-assisted, human-published

02/01/2024 /Funding Events

Avation Medical Secures Over $22 Million for Wearable Neuromodulation System

Avation Medical secures over $22 million in its Series C funding round to launch the Vivally System, a groundbreaking wearable neuromodulation device for treating overactive bladder conditions.

 

AI-assisted, human-published

Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com